Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

Walgreens shares fell more than 5% Friday as details about a potential sale emerged and one analyst team said the stock had ...

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to ...

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

Wall Street's main indexes were mixed in choppy trading on Friday as investors avoided large bets after data showed consumer ...

S&P 500 rises Friday despite stagflation fears. Safe-haven stocks outperform, while Nvidia, Dell, and HP Inc. slide on ...

Most analysts are staying on the sidelines. Of the 18 analysts covering WBA tracked by S&P Global Market Intelligence, four ...

Wall Street's indexes displayed mixed results on Friday amid concerns over a potential economic slowdown. The Commerce ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

In the waning days of the Biden administration, the Labor Department added ovarian, uterine, cervical, and breast cancer coverage for wildland firefighters. It’s unclear whether the new protections ...

From Walgreens' breakup to Forever 21's pending bankruptcy, M&A and drama unfold in this week's edition of Deal Dispatch.